The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Metabolomics: an emerging but powerful tool for precision medicine
Open accessAbstract
Metabolomics, which is defined as the comprehensive analysis of metabolites in a biological specimen, is an emerging technology that holds promise to inform the practice of precision medicine. Historically, small numbers of metabolites have been used to diagnose complex metabolic diseases as well as monogenic disorders such as inborn errors of metabolism. Current metabolomic technologies go well beyond the scope of standard clinical chemistry techniques and are capable of precise analyses of hundreds to thousands of metabolites. Consequently, metabolomics affords detailed characterization of metabolic phenotypes and can enable precision medicine at a number of levels, including the characterization of metabolic derangements that underlie disease, discovery of new therapeutic targets, and discovery of biomarkers that may be used to either diagnose disease or monitor activity of therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W.-M., Fiehn, O., Goodacre, R., Griffin, J. L., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0082-2 · Cited by 5,368
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Self-citationHMDB 3.0—The Human Metabolome Database in 2013
Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1065 · Cited by 2,845
A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS
Guthrie, R., & Susi, A. (1963) · Pediatrics · doi:10.1542/peds.32.3.338 · Cited by 2,219
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
Gross, S., Cairns, R. A., Minden, M. D., Driggers, E. M., Bittinger, M. A., Jang, H. G., Sasaki, M., Jin, S., Schenkein, D. P., Su, S. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092506 · Cited by 736
Haug, K., Salek, R. M., Conesa, P., Hastings, J., de Matos, P., Rijnbeek, M., Mahendraker, T., Williams, M., Neumann, S., Rocca-Serra, P., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1004 · Cited by 651
Mayers, J. R., Wu, C., Clish, C. B., Kraft, P., Torrence, M. E., Fiske, B. P., Yuan, C., Bao, Y., Townsend, M. K., Tworoger, S. S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3686 · Cited by 649
Self-citationRhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44442 · Cited by 647 · cited 2×
“…find early metabolic indicators of disease in longitudinal cohorts years before symptoms are clinically apparent—for example, in pancreatic cancer (Mayers et al. 2014), type 2 diabetes (Rhee et al. 2011, Wang et al. 2011; 2013), memory impairment (Mapstone et al. 2014), and many other conditions.”
BackgroundSelf-citationPyruvate carboxylase is critical for non–small-cell lung cancer proliferation
Sellers, K., Fox, M. P., Bousamra, M., Slone, S. P., Higashi, R. M., Miller, D. M., Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci72873 · Cited by 497
A history of blood glucose meters and their role in self-monitoring of diabetes mellitus
Clarke, S. F., & Foster, J. R. (2012) · British Journal of Biomedical Science · doi:10.1080/09674845.2012.12002443 · Cited by 456
The Metabolomics Standards Initiative
MSI Board Members: (2007) · Nature Biotechnology · doi:10.1038/nbt0807-846b · Cited by 454
2-Aminoadipic acid is a biomarker for diabetes risk
Wang, T. J., Ngo, D., Psychogios, N., Dejam, A., Larson, M. G., Vasan, R. S., Ghorbani, A., O’Sullivan, J., Cheng, S., Rhee, E. P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64801 · Cited by 452
Self-citationThe search for new cardiovascular biomarkers
Gerszten, R. E., & Wang, T. J. (2008) · Nature · doi:10.1038/nature06802 · Cited by 358
Kuehnbaum, N. L., & Britz-McKibbin, P. (2013) · Chemical Reviews · doi:10.1021/cr300484s · Cited by 354
Imaging Metabolism with Hyperpolarized 13C-Labeled Cell Substrates
Brindle, K. M. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b03300 · Cited by 194
Martin, J., Maillot, M., Mazerolles, G., Verdu, A., Lyan, B., Migné, C., Defoort, C., Canlet, C., Junot, C., gualbert, G. C., et al. (2014) · Metabolomics · doi:10.1007/s11306-014-0740-0 · Cited by 136
The Pivotal Role of FDG-PET/CT in Modern Medicine
Hess, S., Blomberg, B. A., Zhu, H. J., Høilund‐Carlsen, P. F., & Alavi, A. A. (2014) · Academic Radiology · doi:10.1016/j.acra.2013.11.002 · Cited by 129
New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma
Dimitrov, L., Hong, C. S., Yang, C., Zhuang, Z., & Heiss, J. D. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.11047 · Cited by 110
Looking back into the future: 30 years of metabolomics at TNO
van der Greef, J., van Wietmarschen, H., van Ommen, B., & Verheij, E. R. (2013) · Mass Spectrometry Reviews · doi:10.1002/mas.21370 · Cited by 64
Cited by
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
Bowden, J. A., Heckert, A., Ulmer, C. Z., Jones, C. M., Koelmel, J. P., Abdullah, L., Ahonen, L., Alnouti, Y., Armando, A. M., Asara, J. M., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m079012 · Cited by 403
The toxicity of nanoparticles and their interaction with cells: an in vitro metabolomic perspective
Awashra, M., & Młynarz, P. (2023) · Nanoscale Advances · doi:10.1039/d2na00534d · Cited by 319
Precision Medicine: Disease Subtyping and Tailored Treatment
Wang, R. C., & Wang, Z. (2023) · Cancers · doi:10.3390/cancers15153837 · Cited by 315
Epidemiology and Risk Factors for Kidney Cancer
Scelo, G., & Larose, T. L. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.1905 · Cited by 305
Metadata
- Authors
- Clish, C. B.
- Venue
- Molecular Case Studies
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2015-09-24
- Volume
- 1
- Issue
- 1
- Pages
- a000588
- ISSN
- 2373-2865 (ISSN-L)
- 2373-2873
- OpenAlex
- W2194890007
- Cited by
- 708
- References
- 23
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.